SLCO1B1 and myopathy: For instance, mutations in SLCO1B1, which encodes the organic anion-transporting polypeptide 1B1 (OATP1B1), have been linked to increased statin-induced myopathy, demonstrating how transporter polymorphisms can impact drug disposition and toxicity [9].